Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 15, Status: Authorised

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): Onpattro, patisiran, Date of authorisation: 27/08/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised

EMA/PE/0000241119

EMA/PE/0000239082

EMA/PE/0000241527

Opinion/decision on a Paediatric investigation plan (PIP): Yorvipath, palopegteriparatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrine disorders, PIP number: EMA/PE/0000241327

EMA/PE/0000238807

EMA/PE/0000232780